Probiotic capsules may speed up COVID recovery, says study IANS Feb 24, 2022 Probiotics are over-the-counter tablets and drinks said to bolster the gut microbiome, the complex intestinal 'soup' made up of…
WHO grants prequalification of Roche’s Actemra/RoActemra for patients with severe COVID EP News Bureau Feb 14, 2022 Since the beginning of the pandemic, more than one million patients with severe COVID-19 have been treated with Actemra/RoActemra,…
New antiviral drug combo highly effective against coronavirus: Study Press Trust of India Feb 10, 2022 The research, published recently in the journal Nature, suggests that these drugs are more potent when used in combination than…
Atrimed Pharmaceuticals introduces capsule that can inhibit viral replication EP News Bureau Jan 19, 2022 The formulation has been tested against the Delta variant and was found to be effective. AI-based studies prove that it is also…
FDA expands authorisation of two monoclonal antibodies for treatment and post-exposure prevention… EP News Bureau Dec 6, 2021 Amlanivimab and Etesevimab are monoclonal antibodies that are specifically directed against the spike protein of SARS-CoV-2,…
New analyses of two AZD7442 COVID-19 phase-III trials in high-risk populations confirm robust… EP News Bureau Nov 19, 2021 Six months' follow-up of prevention trial showed 83 per cent reduced risk of symptomatic COVID-19, with no severe disease or…
ZD7442 reduces risk of developing severe COVID-19 or death in Tackle phase-III outpatient treatment… EP News Bureau Oct 12, 2021 AZD7442 is the only long-acting antibody combination shown to both prevent and treat COVID-19
Thailand in talks with Merck for anti-COVID pills Reuters Oct 5, 2021 Many Asian countries are scrambling to lock in supplies of the potential treatment early after they lagged behind Western nations…
Ronapreve shows positive results in COVID patients EP News Bureau Oct 1, 2021 Data from phase II/III 2066 study by Roche show that Ronapreve significantly reduced viral load within seven days of treatment in…
MSF demands newest COVID-19 treatment recommended by WHO must be accessible to all EP News Bureau Sep 27, 2021 Regeneron, which produces the two-drug treatment cocktail casirivimab/imdevimab, must ensure affordable pricing and adequate…